Navigation Links
New agent may enhance effectiveness of radiotherapy
Date:5/13/2014

Scientists from The University of Manchester part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumour growth.

There is increasing interest in using the body's own immune system to attack tumour cells a strategy that can be very effective without the side effects associated with conventional chemotherapy.

Skin cancers have been successfully treated using a topical cream, imiquimod, which recruits immune cells through a molecule known as toll-like receptor 7 (TLR7), a protein that recognises foreign and potentially harmful material.

Previously, researchers in Manchester have shown that they can also stimulate the immune system into generating an immune response against non-skin cancers by injecting an agent similar to TLR7 into the blood.

In collaboration with AstraZeneca and Dainippon Sumitomo Pharma, the Manchester group have looked at another molecule that activates TLR7, known as DSR-6434. Using mouse models of two different types of cancer, they investigated DSR-6434 on its own and in combination with radiotherapy and measured the effect on the primary tumour and the number of secondary tumours in the lungs.

Professor Ian Stratford, from Manchester Pharmacy School who, with Professor Tim Illidge, led the research published in the International Journal of Cancer, said: "We have already seen a strong immune system response from other immunotherapy agents in combination with radiation this new agent appears to be even more potent."

His team showed that administering DSR-6434 together with radiotherapy led to tumour shrinkage and increased long-term survival. They found that the combination treatment also reduced the occurrence of secondary lung tumours.

"It looks like there's good reason to use radiotherapy alongside immunotherapy agents in the treatment of solid tumours. These results strong
'/>"/>

Contact: Ali Barbuti
alison.barbuti@manchester.ac.uk
44-016-127-58383
University of Manchester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pig stomach mucins are effective as anti-viral agents for consumer products
2. Imaging agents predict breast cancer response to endocrine therapy
3. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
4. New substances 15,000 times more effective in destroying chemical warfare agents
5. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
6. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
7. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
8. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
9. Rilpivirine for HIV: Added benefit for single agent proven
10. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
11. Investigational agent targets gene signaling pathways to improve response for patients with CLL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 The Suspension ... this workout program was developed by Dan Long, a ... well-known as a fitness professional and life coach. The ... and having toned muscles is not impossible , The ... on suspension training. Suspension training promises efficiency when it ...
(Date:10/31/2014)... October 31, 2014 Urban Hydroponics, Inc. ... today announced it has signed a Binding Letter of ... the urban cultivation sector - Urban Cultivator Inc. (“Urban ... and W3 Metal Inc. (“W3 Metal” and together with ... Pursuant to the LOI and an earlier non-binding ...
(Date:10/31/2014)... October 31, 2014 Florida Air ... and girls in grades 6-12, is taking the ... sports injuries and concussions, becoming the first high ... ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) computerized ... NFL Player' lawsuit grabs the headlines, and the ...
(Date:10/31/2014)... NY (PRWEB) October 31, 2014 In an ... York patients, Dr. Majid Jamali announced he will soon offer ... practice by the end of November. , To build ... Maxillofacial Surgery of New York has become known for, Dr. ... boasts degrees from such top learning institutions as UCLA, Stanford ...
(Date:10/31/2014)... 2014 Phoenix dentist , Dr. Christy, ... November. Whether patients simply need routine care or have a ... than now to get that necessary care. The right dental ... routine and even essential treatments due to financial concerns. Throughout ... on any treatments offered by the team at Christy Dental ...
Breaking Medicine News(10 mins):Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2
... and preschool-aged children may be a significant risk factor ... the September issue of Archives of Pediatrics & ... napping does not appear to be an adequate substitute ... "Obesity defined as having age- and sex-specific ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. ... at least if you,re bringing in about $75,000 a year, ... household incomes up to about $75,000, beyond that, earning more ... study. But that doesn,t mean you should give up ...
... 3 (HealthDay News) -- Scientists report that they may have ... early to know if the findings could lead to earlier ... diagnose autism in the second year of life or later, ... at Children,s Hospital of Philadelphia, explained in an interview. Earlier ...
... HealthDay Reporter , FRIDAY, Sept. 3 (HealthDay News) -- ... and high-end offices, bedbugs are popping up in droves although, ... just your bed. According to a National ... U.S. pest management companies surveyed said they had "encountered a ...
... (Geneva, Switzerland) Following the imprisonment of Maxim Popov in ... promotion of HIV prevention efforts in Uzbekistan, the International AIDS ... practitioner working in HIV prevention in Ukraine. Dr. Illya ... for people using drugs, was detained on 28 May 2010 ...
... , FRIDAY, September 3 (HealthDay News) -- A 7-year-old San Diego ... trip to Switzerland a couple years ago. While there, he ... to have him vaccinated against. Upon his return to the United ... story -- a true tale -- is the type of nightmare ...
Cached Medicine News:Health News:Short nighttime sleep duration among infants, young children associated with obesity in later life 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 3Health News:Infants May Display Subtle Autism Signs at 6 Months: Study 2Health News:Bedbug Nation: Critters Make a Comeback 2Health News:Bedbug Nation: Critters Make a Comeback 3Health News:Bedbug Nation: Critters Make a Comeback 4Health News:IAS calls for an end to harassment, intimidation and imprisonment of HIV professionals 2Health News:IAS calls for an end to harassment, intimidation and imprisonment of HIV professionals 3Health News:Disease May Be Only a Plane Ride Away 2Health News:Disease May Be Only a Plane Ride Away 3
(Date:10/31/2014)... 2014 Investor-Edge has initiated coverage on ... Abbott Laboratories (NYSE: ABT ), Hologic Inc. (NASDAQ: ... ), and Covidien PLC (NYSE: COV). Free research on these ... The US markets on Thursday, October 30, 2014, ended ... finished at 17,195.42, up 1.30% and the NASDAQ Composite closed ...
(Date:10/31/2014)... SAN FRANCISCO , Oct. 31, 2014 /PRNewswire/ ... innovative therapeutics, today announced a $26.5 million Series ... global investment firm founded by a team of ... sciences.  Other investors participating in the round include ... Venture Fund.  Representatives from Clarus Ventures and Frazier ...
(Date:10/31/2014)... announces the list of stocks featured in the Analyst Blog. Every ... events impacting stocks and the financial markets. Stocks recently featured in ... Report ), Celgene (Nasdaq: CELG - Free Report ... ), Market Vectors Biotech ETF (AMEX: BBH - ... XBI - Free Report ). Today, Zacks is ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
... Treatment Should Become a Standard of Care, WASHINGTON, ... presented today at the Society of Interventional,Radiology,s 33rd Annual ... Trellis device breaks up a blood clot in most ... the device is guided,directly to the clot via a ...
... Phase I/II data showed that Enhanze Technology(TM) enabled subcutaneous, ... patients with ... Primary Immunodeficiency, PHILADELPHIA, March ... the preliminary results of a Phase I/II,clinical trial, in which ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 2Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 3Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 4Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 5Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 6Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 7
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Dot matrix pattern for light eyed patients....
Natural eye color change for even the darkest of eyes....
Medicine Products: